Dr. Vargas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5777 E. Mayo Boulevard
Phoenix, AZ 85050- Is this information wrong?
Education & Training
- UPMC Medical EducationFellowship, Gastroenterology, 1994 - 1997
- University of Utah HealthResidency, Internal Medicine, 1991 - 1994
- University of Utah HealthInternship, Internal Medicine, 1991 - 1992
- Drexel University College of MedicineClass of 1991
- Hahnemann University Graduate SchoolM.S., Applied Human Physiology, 1986 - 1989
- University of California, DavisB.S., Physiology, 1982 - 1986
Certifications & Licensure
- AZ State Medical License 1999 - 2025
- CO State Medical License 2014 - 2025
- MN State Medical License 2003 - 2024
- UT State Medical License 1992 - 2022
- NV State Medical License 2003 - 2021
- PA State Medical License 1995 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Fellow (FAASLD) American Association for the Study of Liver Diseases, 2014
- Outstanding Program Director of the Year Mayo Clinic College of Medicine, 2010
- Top 10 % Reviewer 2008 Annals of Internal Medicine, 2009
- Join now to see all
Clinical Trials
- MMF Influence on HCV Viral Evolution After Liver Transplantation Start of enrollment: 2002 Sep 01
- Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Start of enrollment: 2006 May 01
- A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin Start of enrollment: 2010 Oct 11
- Join now to see all
Publications & Presentations
PubMed
- Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis.Jasmohan S Bajaj, Patrick S Kamath, K Rajender Reddy, Sumeet K Asrani, Andrew P Keaveny, Puneeta Tandon, Andres Duarte-Rojo, Matthew Kappus, Elizabeth Verna, Scott W B...> ;The American Journal of Gastroenterology. 2024 Apr 1
- Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy.Louissaint, J., Vargas, H.> ;The American Journal of Gastroenterology. 2024 Feb 16
- Not Your Typical Hyperammonemia: Non-hepatic Severe Hyperammonemia in an Adult.Barnhill, M., Yaman, R., Renszel, K., Alzubaidi, S., Vargas, H., Chascsa, D.> ;ACG Case Reports Journal. 2023 Dec 1
- Join now to see all
Journal Articles
- Care of the patient with cirrhosisYadav A, Vargas HE, Clinical Liver Disease, 1/1/2015
- Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGETGordon SC, Muir AJ, Lim JK, Pearlman B, Argo CK, Ramani A, Maliakkal B, Alam I, Stewart TG, Vainorius M, Peter J, Nelson DR, Fried MW, Reddy KR, on behalf of the HCV-T..., Journal of Hepatology, 1/1/2015
- Hepatitis c guidance: aasld-idsa recommendations for testing, managing, and treating adults infected with hepatitis c virusChung RT, Davis GL, Jensen DM, Masur H, Saag MS, Thomas DL, Aronsohn AI, Charlton MR, Feld JJ, Fontana RJ, Ghany MG, Godofsky EW, Graham CS, Kim AY, Kiser JJ, Kottilil..., Hepatology, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Child-Turcotte-Pugh (CTP) score is best at predicting 6-week mortality in patients with acute variceal hemorrhage (avh): analysis of a US multi-center prospective ...Fortune BE, Garcia-Tsao G, Ciarleglio M, Deng YH, Fallon MB, Sigal S, Chalasani NP, Lim JK, Reuben A, Abrams G, Lewis MB, Hassanein T, Trotter JF, Sanyal AJ, Beavers K..., Hepatology, 1/1/2014
- Multicenter experience using sofosbuvir and simeprevir with/without ribavirin to treat hcv genotype 1 after liver transplantationPungpapong S, Werner KT, Aqel B, Leise MD, Murphy JL, Henry TM, Ryland K, Chervenak AE, Watt KD, Keaveny A, Hepatology, 1/1/2014
- The use of simeprevir and sofosbuvir to treat hcv g1 in the liver transplant setting: the experience in 3 US centersAqel B, Pungpapong S, Werner KT, Chervenak AE, Rakela J, Watt KD, Leise MD, Murphy JL, Henry TM, Ryland K, Keaveny A, Hepatology, 1/1/2014
- Join now to see all
Lectures
- Current and Future Management of Prior Difficult-to-Treat HCV PatientsHouston, TX - 1/1/2015
- Debate: Treat All Stages of Fibrosis of Chronic-HCV Now!Houston, TX - 1/1/2015
- HCV Treatment for 2014: The New Direct Anti-viralsScottsdale, AZ - 1/1/2014
- Join now to see all
Grant Support
- HCV Quasispecies Dynamics And Liver TransplantNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- HCV Quasispecies Dynamics And Liver TransplantNational Institute Of Diabetes And Digestive And Kidney Diseases2003
Professional Memberships
- Fellow
- Fellow
- Fellow
Other Languages
- Spanish
Hospital Affiliations
- Mayo Clinic HospitalPhoenix, Arizona
- Mayo Clinic HospitalPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: